Top 10 Pharma Companies in Japan by Market Capitalization

Daiichi Sankyo Co Ltd, Takeda Pharmaceutical Co Ltd, Chugai Pharmaceutical Co Ltd, Astellas Pharma Inc, and Otsuka Holdings Co Ltd are the top 5 pharma companies in Japan by market capitalization (as of Mar 31, 2023). Comprehensively, the top 10 companies had a total market cap of $265,509 million (as of Mar 31, 2023), with Daiichi Sankyo Co Ltd having the highest ($70,777 million), followed by Takeda Pharmaceutical Co Ltd ($51,888 million), and Chugai Pharmaceutical Co Ltd ($41,391 million), while Rohto Pharmaceutical Co Ltd is the lowest ($4,932 million). Daiichi Sankyo Co Ltd is the leading pharma company in Japan by market cap (as of Mar 31, 2023). The company reported revenues of $9,302 million for the fiscal year ended March 2022 (FY2022), an increase of 8.6% over FY2021. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, vaccines, and others. It employs 16,458 people. Takeda Pharmaceutical Co Ltd is another leading pharma company in Japan by market cap (as of Mar 31, 2023). The company reported revenues of $31,773 million for the fiscal year ended March 2022 (FY2022), an increase of 11.6% over FY2021. The company offers products in the areas of rare diseases, gastrointestinal, oncology, neuroscience, vaccines, and plasma-derived therapies. It employs 47,347 people.